Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hinrich Abken

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Human Gene Therapy|August 18, 2021
Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen ReceptorsHinrich Abken
Transplantation|June 22, 2021
IL-2 "Backpacking" Invigorates Treg Cells to Prevent Allograft RejectionHinrich Abken
Immunotherapy|June 13, 2015
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumorsHinrich Abken
Human Gene Therapy|August 17, 2017
Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T CellsHinrich Abken
Cancer Immunology Research|July 22, 2024
Transforming the Dark into Light: A Siglec-9 SwitchHinrich Abken
Immunity|February 18, 2016
Costimulation Engages the Gear in Driving CARsHinrich Abken
Nature Reviews. Gastroenterology & Hepatology|April 14, 2025
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challengesHinrich Abken
Pharmacology|June 13, 2022
Treatment with Living Drugs: Pharmaceutical Aspects of CAR T CellsAstrid Holzinger, Hinrich Abken
Clinical & Translational Immunology|June 26, 2019
Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumorsJordan Hartley, Hinrich Abken
Cancer Immunology, Immunotherapy : CII|July 30, 2017
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe targetAstrid Holzinger, Hinrich Abken
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Human Gene Therapy|August 18, 2021
Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen ReceptorsHinrich Abken
Transplantation|June 22, 2021
IL-2 "Backpacking" Invigorates Treg Cells to Prevent Allograft RejectionHinrich Abken
Immunotherapy|June 13, 2015
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumorsHinrich Abken
Human Gene Therapy|August 17, 2017
Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T CellsHinrich Abken
Cancer Immunology Research|July 22, 2024
Transforming the Dark into Light: A Siglec-9 SwitchHinrich Abken
Immunity|February 18, 2016
Costimulation Engages the Gear in Driving CARsHinrich Abken
Nature Reviews. Gastroenterology & Hepatology|April 14, 2025
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challengesHinrich Abken
Pharmacology|June 13, 2022
Treatment with Living Drugs: Pharmaceutical Aspects of CAR T CellsAstrid Holzinger, Hinrich Abken
Clinical & Translational Immunology|June 26, 2019
Chimeric antigen receptors designed to overcome transforming growth factor-β-mediated repression in the adoptive T-cell therapy of solid tumorsJordan Hartley, Hinrich Abken
Cancer Immunology, Immunotherapy : CII|July 30, 2017
CAR T cells targeting solid tumors: carcinoembryonic antigen (CEA) proves to be a safe targetAstrid Holzinger, Hinrich Abken
Pageof 18